Joint EIT Health Germany & EIT Health Scandinavia Symposium

E-Health and Crisis –
How the COVID-19 pandemic accelerated the adoption of digital solutions within European Healthcare Systems

 

Since spring 2020, the rapid spread of the COVID-19 virus brought our way of life to a standstill. Throughout all areas of society and government, we had to walk new ways and redesign familiar structures to face previously unknown challenges.

All industries had to adjust to the changed situation, but hardly any other industry was as strongly challenged to adapt as the health sector. Hospitals and medical facilities were required to exhaust their capacities whilst simultaneously implementing the necessary changes brought upon them by the pandemic to protect healthcare workers as well as patients. Some of these adaptations have transformed the European health sector forever due to digital solutions having been adopted within European Healthcare Systems during the pandemic at a previously unimaginable pace and scale.

 

This Joint EIT Health Germany &EIT Health Scandinavia Symposium will provide EIT Health partners and associated organisations from across the D.A.CH. region as well as from Sweden, Denmark, Finland, Estonia with a cross-border platform to exchange experiences and learnings from the frontline of this transformation of the respective healthcare systems.

Register via Eventbrite.

 

 

AGENDA

19 October 2021:

11:30-11:50 Welcome | Dr. Katharina Ladewig (EIT Health Germany), Erik Forsberg (EIT Health Scandinavia), Video message by Theresia Bauer, Minister of Science, Research and Art Baden-Wuerttemberg

11:50-12:25 Keynote 1| Digital platform economy in the social economy | Johannes Walter, Referent für digitale Verbandsentwicklung, Das Diakonische Werk der Evangelischen Landeskirche in Baden e.V. presentation 

12:25-13:00 Keynote 2| Danish digital infection preparedness, Statens Serum Institute implementing the corona-passport – A view from Denmark | Marianne Voldstedlund, Sektionsleder, Infektionsberedskab, Statens Serum Institute presentation

13:00-14:00 Lunch Break

14:00-17:00 How the COVID-19 pandemic accelerated the adoption of digital solutions – Learnings from across Europe | multiple speakers

  • 14:00 – 14:25 Telehealth Services for Chronic Disease Management and Tele-Rehabilitation: Challenges and Chances Due to the COVID-19 Pandemic (Angelika Rzepka; AIT)
  • 14:25 – 14:50 Lybe Scientific – High Quality diagnostic solutions (COVID-Test) (Tonje Steigedal, NTNU)
  • 14:50 – 15:15 Remote Decentralised Clinical Trials: Towards more sustainability, resilience and external validity in pivotal clinical research (Prof. Dr. Freimut Schliess, PROFIL) presentation
  • 15:15 – 15:40 FHabian, a digiphysical cascade screening model to diagnose Familial Hypercholesterolemia in Sweden (Lovisa Schalin and Joakim Söderberg, Amgen)
  • 15:40 – 15:45 5min break
  • 15:45 – 16:10 Digital-technology based interventions for treatment of migraine (Katrina Laks; Tartu University and Migrevention) presentation
  • 16:10 – 16:35 The coronavirus pandemic puts Intensive Care Medicine to the test (Dr. med. Lukas Martin; RWTH Aachen)
  • 16:35 – 17:00 The fractures of change in e-Health during COVID-19 pandemic (Karl-Henrik Peterson; Haigekassa) presentation

20 October 2021:

9:30-9:40 Welcome

9:40-10:00 Keynote | Nordic edge: the power of collective action – How unfamiliar Nordic stakeholders came together to lift health tech in a time of need | Valentin Bejan, Copenhagen Health Tech Hub presentation

10:00-10:10 Starting future collaborations DACH & Scandinavia | National and European funding opportunities in the DACH Region, Scandinavia and Europe | Dr Katharina Ladewig (EIT Health Germany), Erik Forsberg (EIT Health Scandinavia)

10:10-11:30 National and European funding opportunities in the DACH Region, Scandinavia and Europe 

  • 10:10 – 10:40           Horizon Europe Funding Opportunities | Sabine Steiner-Lange, German NCP for Horizon Europe presentation
  • 10:40 – 11:05           Interreg Baltic Sea Project | Elea Nova, INTERREG presentation
  • 11:05 – 11:30           Funding and collaboration opportunities | Bianca Dochtorowicz, Vinnova – Sweden’s Innovation Agency presentation

11:30-11:45 Morning Tea Break

11:45-12:45 Innovation Marketplace | Pitches by Certify Health presentation, Help-Doctor presentation, Doctolib presentation, Care to Translate, Life Science Factory presentation, Boehringer Ingelheim presentation, Digi-B-Cube presentation, and Bio RN presentation

12:45-13:00 What have we learned? Where do we go? – Q&A session

13:00-13:15 Closing of Event & Next steps | Dr Katharina Ladewig (EIT Health Germany), Erik Forsberg (EIT Health Scandinavia) | Anna Sandström, Director Science Policy and Relations Europe at AstraZeneca

13:00-14:00 Lunch Break

14:00-16:00 Closed Session | German Partner Meeting (German Partners only)

Presentations

Keynote: Statens Serum Institute implementing the corona passport - A view from Denmark

19 Oct | 12:25
Marianne Voldstedlund, Sektionsleder, Infektionsberedskab

Telehealth Services for Chronic Disease Management and Tele-Rehabilitation: Challenges and Chances Due to the COVID-19 Pandemic

19 Oct | 14:00
Angelika Rzepka

Lybe Scientific – High Quality diagnostic solutions (COVID-Test)

19 Oct | 14:25
Tonje Steigedal

Remote Decentralised Clinical Trials: Towards more sustainability, resilience and external validity in pivotal clinical research?

19 Oct | 14:50
Prof. Dr. Freimut Schliess

FHabian, a digiphysical cascade screening model to diagnose Familial Hypercholesterolemia in Sweden

19 Oct | 15:15
Lovisa Schalin

Digital-technology based interventions for treatment of migraine

19 Oct | 15:45
Katrina Laks

The coronavirus pandemic puts Intensive Care Medicine to the test

19 Oct | 16:10
Dr. med. Lukas Martin

The fractures of change in e-Health during COVID-19 pandemic

19 Oct | 16:35
Karl-Henrik Peterson

Nordic edge: the power of collective action

20 Oct | 9:40ds
Valentin Bejan

Our speakers

Johannes Walter (Das Diakonische Werk der Evangelischen Landeskirche in Baden e.V.)

Marianne Voldstedlund (Statens Serum Institute)

Head of Section: Data Integration and Analysis; Division of Infection preparedness; Statens Serum Institut.

Education: MD, Ph.D, consultant and specialist in clinical microbiology

 

Marianne has spent day and night during the epidemic to organize the integration and use of lab- and register data, and furthermore been involved in the development of new digital solutions. She has furthermore been involved in Statens Serum Institut’s role as government advisor.

 

M Voldstedlund has a special interest in bridging the gaps between Clinical Microbiology, Public Health medicine and IT-technology. M Voldstedlund is responsible for developing a national digital surveillance system for infectious diseases.

Angelika Rzepka (AIT)

Angelika Rzepka is a Scientist at the AIT – Austrian Institute of Technology GmbH. She holds a master degree in Health Care Engineering and a second master degree in Public Health. She is responsible for coordinating projects in the business unit Digital Health Information Systems and writes competitive proposals for public funding. She mainly concentrates on integrated care networks and according care paths, as well as accessibility for TeleHealth solutions in Austria’s public health system.

Tonje Steigedal (Norwegian University of Science and Technology)

CEO and Co-founder for Lybe Scientific. I have a background as MSc in Biotechnology and PhD in Medical Technology. Worked with cancer research at NTNU and MIT before I started to work as a Business Developer at NTNU Technology Transfer focusing on medical technology and life science ideas.

Prof. Dr. Freimut Schliess (PROFIL Institut für Stoffwechselforschung GmbH)

Freimut Schliess heads Science & Innovation at Profil GmbH (www.profil.com) – a CRO for early phase clinical trials in diabetes, NAFLD and cardiovascar disease. Freimut is leading the CLOSE and RealWorld4Clinic EIT Health innovation initiatives. In iPDM-GO he contributes to exploring the usage of epidemiological data and artificial intelligence tools for adapting diabetes management to the requirements of Value Based Healthcare. One of his ambitions is to close the gap between the outcomes of well controled clinical trials and the effectiveness of treatments in real world healthcare.

Lovisa Schalin (AMGEN)

Sr Medical Advisor Cardiovascular, kAmgen and initiator of FHabian.

MSc Katrina Laks (Tartu University + Migrevention)

Priv.-Doz. Dr. med. Lukas Martin (MHBA)

Founder, Chief Executive Officer, Intensive Care Specialist

  • Study of medicine in Aachen, MBA in Nürnberg
  • Senior physician at the clinic for Operative Intensive Care and Intermediate Care (Uniklinik RWTH Aachen)
  • Habilitation and Venia legendi for anaesthesiology and intensive care
  • Senior Lecturer for Business in Translational Medicine at the Queen Mary University London
  • Leader of the task force “Artificial Intelligence Lab (AI4CC)” of the Uniklinik RWTH Aachen

Karl-Henrik Peterson (Eesti Haigekassa)

Karl H. Peterson is the member of management board of the Estonian Health Insurance Fund who is responsible for digitalization and change within the organization and across the Estonian healthcare sector.

He has held multitude of different roles throughout his 25-year career covering most IT related areas from specialist to top management in financial institutions. He has held key roles during four different global crises learning how to turn a crisis into an advantage.

Karl has experience in rapid changes involving large projects over multiple culture spaces and countries and can attest to Nassim Nicholas Talebs wise words „History and societies do not crawl. They make jumps. They go from fracture to fracture, with a few vibrations in between.“

Valentin Bejan (Copenhagen Health Tech Hub)

Co-founder of Health Tech Hub Copenhagen, driving up the scaling and adoption of clever, responsible health tech.

Former Head of Innovation at Momentum Mental Healthcare (Netherlands). Worked on prevention models and expanding care outside of the clinics. As top-tier management consultant, helped health and tech clients on four continents. Digital Vanguard for Exponential Medicine.

Anna Sandström (AstraZenecka)

A physicist by training, with a PhD in Molecular Biophysics from Karolinska Institutet and a career at Government Agencies such as Vinnova and the Ministry of Enterprise and Innovation, Anna Sandström is today Science Policy and Relations Director for Europe at AstraZeneca, with focus on Sweden, United Kingdom and EU. She is elected member of the Royal Swedish Academy of Engineering Sciences and is board member of the Royal Institute of Technology and the synchrotron light source MaxIV as well as EIT Health Scandinavia and heads the R&D committee of the trade body SwedenBIO.

Looking back at EIT Health Germany joint Symposium with EIT Health Innostars 2020

In 2020, EIT Health Germany and EIT Health Innostars invited stakeholders and representatives from inside and outside of the EIT Health ecosystem to debate in the area of the very important and currently hotly discussed topic „Value-Based Health Care in Europe“. Are you interested in the presentations held and the outcomes of the workshops? Then click here for more detail.

Call for abstracts: CLOSED

 

Submissions of abstracts focussing on any of the above mentioned (and related) topics are invited from any EIT Health core, associate and network partner associated with either EIT Health Germany or EIT Health Scandinavia. We are also explicitly inviting all associated organisations from the respective local ecosystems in Germany, Austria, Switzerland, Sweden, Denmark, Finland, or Estonia to share their experiences.

 

Abstract submission deadline: ended on 10-Sept-2021    

Please download the template here and email your completed abstract to clc.germany@eithealth.eu by the due date. You will be informed in writing of whether your abstract has been selected for the programme and at what time your presentation is scheduled, no later than 3 weeks prior to the event.

 

Additional opportunity for start-ups, scale-ups and SMEs:

On Day 1 of the symposium, start-ups, scale-ups and SMEs associated with EIT Health Germany or EIT Health Scandinavia will have the opportunity to present their technologies and collaboration offers/needs as part of the innovation marketplace. Please use the abstract template to briefly describe your company, technology and collaboration offer/need and send this to clc.germany@eithealth.eu by the abstract due date (see above). You will be informed in writing whether you will receive the opportunity to present at the innovation marketplace at least 2 weeks prior to the event.